The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This accredited education brings together a diverse healthcare team to discuss the latest evidence and clinical strategies in GI oncology and hepatopancreatobiliary (HPB) care. Participants, including physicians, nurses, pharmacists, trainees, and other healthcare professionals, will engage in multidisciplinary tumor board sessions featuring real patient cases, review of clinical predictors for treatment response, and discussion of emerging therapeutic techniques. Through collaborative, case-based conversations and expert guidance, participants will refine their approach to chemotherapy, radiation, and procedural interventions. The activity ultimately supports improved decision-making and individualized care, aiming for better survival and quality of life for patients with GI and HPB cancers.

Facebook
X
LinkedIn
Forward